The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug

Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial

(2010) S. Saevarsdottir et al.   ANNALS OF THE RHEUMATIC DISEASES

Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: Observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Reg

(2010) Saedis Saevarsdottir et al.   ARTHRITIS AND RHEUMATISM

Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment

(2009) Lisa K. Stamp et al.   ARTHRITIS AND RHEUMATISM

Disease activity level, remission and response in established rheumatoid arthritis: Performance of various criteria sets in an observational cohort, treated with anti-TNF agents

(2009) Anders Gülfe et al.   BMC MUSCULOSKELETAL DISORDERS

Anti-TNF-α Agents Are Less Effective for the Treatment of Rheumatoid Arthritis in Current Smokers

(2009) A Abhishek et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Relationship Between Pack-year History of Smoking and Response to Tumor Necrosis Factor Antagonists in Patients with Rheumatoid Arthritis

(2009) D. L. MATTEY et al.   JOURNAL OF RHEUMATOLOGY

Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological group

(2008) G. Westhoff et al.   RHEUMATOLOGY